JCOG1301C: A randomized phase II study of systemic chemotherapy with and without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2019
This article has no abstract
Epistemonikos ID: 6e00d70a072c05bcb68afdc48af751e618be9487
First added on: Apr 11, 2025